Sensorion SA banner

Sensorion SA
PAR:ALSEN

Watchlist Manager
Sensorion SA Logo
Sensorion SA
PAR:ALSEN
Watchlist
Price: 0.612 EUR 5.52%
Market Cap: €315.1m

Sensorion SA
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sensorion SA
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Sensorion SA
PAR:ALSEN
Research & Development
-€24.9m
CAGR 3-Years
-9%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genfit SA
PAR:GNFT
Research & Development
-€40.6m
CAGR 3-Years
-25%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Inventiva SA
PAR:IVA
Research & Development
-€86.2m
CAGR 3-Years
-14%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
DBV Technologies SA
PAR:DBV
Research & Development
-$95.9m
CAGR 3-Years
-13%
CAGR 5-Years
9%
CAGR 10-Years
-16%
Abivax SA
PAR:ABVX
Research & Development
-€199.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sensorion SA
Glance View

Market Cap
315.1m EUR
Industry
Biotechnology

Sensorion SAS is a biopharmaceutical company, which engages in the development of therapies to treat and prevent diseases of the inner ear such as deafness, vertigo and tinnitus. The company is headquartered in Montpellier, Occitanie and currently employs 34 full-time employees. The company went IPO on 2015-04-21. The firm is principally active in the development of targeted therapeutic solutions to treat inner ear diseases. The firm develops also drug treatments, from molecular biology all the way to animal pharmacology, toxicology, and clinical research and therapeutic solutions to treat vestibular deficits. Sensorion SA is a spin-off of the research team Pathophysiology and Therapy of Vestibular Deficits in Montpellier Neuroscience Institute.

ALSEN Intrinsic Value
0.099 EUR
Overvaluation 84%
Intrinsic Value
Price

See Also

What is Sensorion SA's Research & Development?
Research & Development
-24.9m EUR

Based on the financial report for Jun 30, 2025, Sensorion SA's Research & Development amounts to -24.9m EUR.

What is Sensorion SA's Research & Development growth rate?
Research & Development CAGR 5Y
-24%

Over the last year, the Research & Development growth was -3%. The average annual Research & Development growth rates for Sensorion SA have been -9% over the past three years , -24% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett